Pluristem Therapeutic Revenue Quarterly YoY Growth:-15.58% for Dec. 31, 2012
Pluristem Therapeutic Revenue Quarterly YoY Growth Chart
Pluristem Therapeutic Historical Revenue Quarterly YoY Growth DataPro Data Export
There is no data for the selected date range.
|Data for this Date Range|
|Dec. 31, 2012||-15.58%|
|Sept. 30, 2012||26.62%|
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
PSTI Revenue Quarterly YoY Growth Benchmarks
|United Therapeutics Corporation||20.04%|
PSTI Revenue Quarterly YoY Growth Rankings
4221 of 7590
417 of 651 in Healthcare
100 of 238 in Biotechnology
PSTI Revenue Quarterly YoY Growth Range, Past 5 Years
GlobeNewswire May 13
GlobeNewswire May 7